Efficacy of a three-component acellular pertussis vaccine (DTaP) in early childhood after household exposure to "typical" (WHO-defined) pertussis.
Schmitt
H J
HJ
Kinderklinik der Johannes Gutenberg-Universität, Mainz, Germany.
D002985:Clinical Protocols; D002986:Clinical Trials as Topic; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D004781:Environmental Exposure; D005192:Family Health; D006801:Humans; D007223:Infant; D011446:Prospective Studies; D014917:Whooping Cough / Q000517:prevention & control* / Q000635:transmission
D015721:Diphtheria-Tetanus-Pertussis Vaccine; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines